Palantir's 'unlimited access' to patient data — we examine the US tech giant's controversial £330 million contract with the NHS
Palantir Technologies has secured a controversial £330 million contract with the NHS, granting it extensive access to patient data. This agreement has sparked significant backlash from privacy advocates and NHS staff, leading to petitions urging the UK government to terminate the contract. Concerns have been raised about the implications for patient confidentiality and the effectiveness of Palantir's data management solutions.
- ▪Palantir's contract with the NHS allows for 'unlimited access' to identifiable patient health data.
- ▪Over 200,000 signatures have been collected on petitions to cancel the contract with Palantir.
- ▪Critics argue that the partnership could compromise patient confidentiality and raise ethical concerns.
TechRadar publishes from United Kingdom and files mainly under tech. We currently carry 1,513 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | TechRadar |
| Canonical URL | https://www.techradar.com/vpn/vpn-privacy-security/palantirs-unlimited-access-to-patient-data-we-examine-the-us-tech-giants-controversial-gbp330-million-contract-with-the-nhs |
| Publication time | Fri, 29 May 2026 15:39:02 +0000 |
| Retrieval time | 2026-05-29T15:45:02.247Z |
| Last seen | 2026-05-29T15:45:02.247Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 1bccIndFbYq- |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
VPN VPN Privacy & Security Palantir's 'unlimited access' to patient data — we examine the US tech giant's controversial £330 million contract with the NHS Features By Chiara Castro published 29 May 2026 Palantir's role in our healthcare is growing — here’s why people are worried and what it means for your privacy When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. (Image credit: Photo by Vincent Feuray / Hans Lucas / AFP via Getty Images) Jump To: Palantir and the NHS Privacy Palantir controversy What you can do Copy link Facebook X Whatsapp Reddit Pinterest Flipboard Threads Email Share this article 0 Join the conversation Follow us Add us as a preferred source on Google Newsletter Subscribe to our newsletter Who would have thought that…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TechRadar.
Discussion
0 commentsMore from TechRadar
